<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Osteoporosis on VitaminDWiki</title><link>/categories/osteoporosis.html</link><description>Recent content in Osteoporosis on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Fri, 16 Dec 2016 00:00:00 +0000</lastBuildDate><atom:link href="/categories/osteoporosis/index.xml" rel="self" type="application/rss+xml"/><item><title>Calcium from plants might be OK</title><link>/posts/calcium-from-plants-might-be-ok.html</link><pubDate>Fri, 16 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/calcium-from-plants-might-be-ok.html</guid><description/></item><item><title>Osteoporosis of Indian men in their 60’s (perhaps low vitamin D, K, and Mg)</title><link>/posts/osteoporosis-of-indian-men-in-their-60s-perhaps-low-vitamin-d-k-and-mg.html</link><pubDate>Mon, 05 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-of-indian-men-in-their-60s-perhaps-low-vitamin-d-k-and-mg.html</guid><description/></item><item><title>Osteoporosis helped by Vitamin D, still not willing to recommend exact dose size</title><link>/posts/osteoporosis-helped-by-vitamin-d-still-not-willing-to-recommend-exact-dose-size.html</link><pubDate>Wed, 23 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-helped-by-vitamin-d-still-not-willing-to-recommend-exact-dose-size.html</guid><description/></item><item><title>Bone diseases related to many Vitamin D diseases</title><link>/posts/bone-diseases-related-to-many-vitamin-d-diseases.html</link><pubDate>Sun, 20 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/bone-diseases-related-to-many-vitamin-d-diseases.html</guid><description/></item><item><title>Osteoporosis treatment guidelines by US Endocrinology groups</title><link>/posts/osteoporosis-treatment-guidelines-by-us-endocrinology-groups.html</link><pubDate>Tue, 20 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-treatment-guidelines-by-us-endocrinology-groups.html</guid><description/></item><item><title>COPD, Osteoporosis, and low Vitamin D</title><link>/posts/copd-osteoporosis-and-low-vitamin-d.html</link><pubDate>Wed, 14 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/copd-osteoporosis-and-low-vitamin-d.html</guid><description>&lt;p>&lt;strong>Osteoporosis Associated with Chronic Obstructive Pulmonary Disease&lt;/strong>&lt;/p>
&lt;p>J Bone Metab 2016;23:111-120 &lt;a href="http://dx.doi">http://dx.doi&lt;/a>.Org/10.11005/jbm.2016.23.3.111 pISSN 2287-6375 eISSN 2287-7029&lt;/p>
&lt;p>Ryo Okazaki, Reiko Watanabe, Daisuke Inoue&lt;/p>
&lt;p>Third Department of Medicine, Teikyo University Chiba Medical Center, Japan&lt;/p>
&lt;p>Corresponding author: Ryo Okazaki, Third Department of Medicine, Teikyo University Chiba Medical Center, 3426-3 Anesaki Ichihara, Chiba 299-0111, Japan Tel: +81-436-62-1211, Fax: +81-436-7340, E-mail: &lt;a href="mailto:rokazaki@med.teikyo-u.ac.jp">rokazaki@med.teikyo-u.ac.jp&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/copd-fought-by-vitamin-d-many-studies">COPD fought by Vitamin D - many studies&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=Glucocorticoid&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for Glucocorticoids&lt;/a> 311 items as of Sept 2016&lt;/p></description></item><item><title>Bones not helped much by vitamin D (low dose or short term) National Osteoporosis Foundation</title><link>/posts/bones-not-helped-much-by-vitamin-d-low-dose-or-short-term-national-osteoporosis-foundation.html</link><pubDate>Wed, 10 Feb 2016 00:00:00 +0000</pubDate><guid>/posts/bones-not-helped-much-by-vitamin-d-low-dose-or-short-term-national-osteoporosis-foundation.html</guid><description>&lt;h4 id="the-national-osteoporosis-foundations-position-statement-on-peak-bone-mass-development-and-lifestyle-factors-a-systematic-review-and-implementation-recommendations">The National Osteoporosis Foundation&amp;rsquo;s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.&lt;/h4>
&lt;p>Osteoporos Int. 2016 Feb 8. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Weaver CM1, Gordon CM2,3, Janz KF4, Kalkwarf HJ5, Lappe JM6, Lewis R7, O&amp;rsquo;Karma M8, Wallace TC9,10,11, Zemel BS12,13.&lt;/p>
&lt;p>Lifestyle choices influence 20-40 % of adult peak bone mass. Therefore, optimization of lifestyle factors known to influence peak bone mass and strength is an important strategy aimed at reducing risk of osteoporosis or low bone mass later in life. The National Osteoporosis Foundation has issued this scientific statement to provide evidence-based guidance and a national implementation strategy for the purpose of helping individuals achieve maximal peak bone mass early in life. In this scientific statement, we (1) report the results of an evidence-based review of the literature since 2000 on factors that influence achieving the full genetic potential for skeletal mass; (2) recommend lifestyle choices that promote maximal bone health throughout the lifespan; (3) outline a research agenda to address current gaps; and (4) identify implementation strategies. We conducted a systematic review of the role of individual nutrients, food patterns, special issues, contraceptives, and physical activity on bone mass and strength development in youth. An evidence grading system was applied to describe the strength of available evidence on these individual modifiable lifestyle factors that may (or may not) influence the development of peak bone mass (Table 1). A summary of the grades for each of these factors is given below. We describe the underpinning biology of these relationships as well as other factors for which a systematic review approach was not possible. Articles published since 2000, all of which followed the report by Heaney et al. &lt;sup>[1]&lt;/sup> published in that year, were considered for this scientific statement. This current review is a systematic update of the previous review conducted by the National Osteoporosis Foundation &lt;sup>[1]&lt;/sup>. Lifestyle Factor Grade Macronutrients  Fat D  Protein C Micronutrients  Calcium A  Vitamin D B  Micronutrients other than calcium and vitamin D D Food Patterns  Dairy B  Fiber C  Fruits and vegetables C  Detriment of cola and caffeinated beverages C Infant Nutrition  Duration of breastfeeding D  Breastfeeding versus formula feeding D  Enriched formula feeding D Adolescent Special Issues  Detriment of oral contraceptives D  Detriment of DMPA injections B  Detriment of alcohol D  Detriment of smoking C Physical Activity and Exercise  Effect on bone mass and density A  Effect on bone structural outcomes B Considering the evidence-based literature review, we recommend lifestyle choices that promote maximal bone health from childhood through young to late adolescence and outline a research agenda to address current gaps in knowledge. The best evidence (grade A) is available for positive effects of calcium intake and physical activity, especially during the late childhood and peripubertal years-a critical period for bone accretion. Good evidence is also available for a role of vitamin D and dairy consumption and a detriment of DMPA injections. However, more rigorous trial data on many other lifestyle choices are needed and this need is outlined in our research agenda. Implementation strategies for lifestyle modifications to promote development of peak bone mass and strength within one&amp;rsquo;s genetic potential require a multisectored (i.e., family, schools, healthcare systems) approach.&lt;/p></description></item><item><title>Osteoporosis is associated with more than vitamin D genes</title><link>/posts/osteoporosis-is-associated-with-more-than-vitamin-d-genes.html</link><pubDate>Sun, 03 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-is-associated-with-more-than-vitamin-d-genes.html</guid><description/></item><item><title>Better bones again associated with higher vitamin K intake</title><link>/posts/better-bones-again-associated-with-higher-vitamin-k-intake.html</link><pubDate>Sat, 14 Nov 2015 00:00:00 +0000</pubDate><guid>/posts/better-bones-again-associated-with-higher-vitamin-k-intake.html</guid><description/></item><item><title>Vitamin D, Calcium and protein very important to bone health</title><link>/posts/vitamin-d-calcium-and-protein-very-important-to-bone-health.html</link><pubDate>Wed, 07 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-calcium-and-protein-very-important-to-bone-health.html</guid><description>&lt;p>&lt;strong>Life-course approach to nutrition&lt;/strong>&lt;/p>
&lt;p>Osteoporos Int DOI 10.1007/s00198-015-3288-6&lt;/p>
&lt;p>P. J. Mitchell1,2 • C. Cooper3,4 • B. Dawson-Hughes • C. M. Gordon • R. Rizzoli, &lt;a href="mailto:cc@mrc.soton.ac.uk">cc@mrc.soton.ac.uk&lt;/a>&lt;/p>
&lt;p>Synthesis Medical NZ Ltd, Auckland, New Zealand&lt;/p>
&lt;p>University of Notre Dame Australia, Sydney, Australia&lt;/p>
&lt;p>NIHR Musculoskeletal Biomedical Research Unit, Nuffield Dept of Orthopaedics, Rheumatology and Musculoskeletal Sciences, U. of Oxford, Oxford, UK&lt;/p>
&lt;p>MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK&lt;/p>
&lt;p>Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA&lt;/p></description></item><item><title>Breast Feeding increased risk of low bone density by 24 percent</title><link>/posts/breast-feeding-increased-risk-of-low-bone-density-by-24-percent.html</link><pubDate>Tue, 06 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/breast-feeding-increased-risk-of-low-bone-density-by-24-percent.html</guid><description>&lt;h4 id="breast-feeding-is-associated-with-postmenopausal-bone-loss-findings-from-the-korea-national-health-and-nutrition-examination-survey">Breast Feeding Is Associated with Postmenopausal Bone Loss: Findings from the Korea National Health and Nutrition Examination Survey.&lt;/h4>
&lt;p>Korean J Fam Med. 2015 Sep;36(5):216-20. &lt;a href="https://doi.org/10.4082/kjfm.2015.36.5.216.">doi: 10.4082/kjfm.2015.36.5.216.&lt;/a> Epub 2015 Sep 18.&lt;/p>
&lt;p>Kim HJ1, Kwon H2, Oh SW2, Lee CM2, Joh HK3, Kim Y1, Um YJ1, Ahn SH1.&lt;/p>
&lt;p>1Department of Family Medicine, Seoul National University Hospital, Seoul, Korea.&lt;/p>
&lt;p>2Department of Family Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea.&lt;/p>
&lt;p>3Health Service Center, Seoul National University, Seoul, Korea.&lt;/p></description></item><item><title>2.8X higher risk of osteoporosis if COPD and modified vitamin D receptor genes</title><link>/posts/28x-higher-risk-of-osteoporosis-if-copd-and-modified-vitamin-d-receptor-genes.html</link><pubDate>Mon, 07 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/28x-higher-risk-of-osteoporosis-if-copd-and-modified-vitamin-d-receptor-genes.html</guid><description/></item><item><title>800 IU Vitamin D proven again to not be enough to stop bone loss</title><link>/posts/800-iu-vitamin-d-proven-again-to-not-be-enough-to-stop-bone-loss.html</link><pubDate>Mon, 03 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/800-iu-vitamin-d-proven-again-to-not-be-enough-to-stop-bone-loss.html</guid><description>&lt;h3 id="vitamin-d-may-not-benefit-postmenopausal-bone-healthhttpwwwreuterscomarticle20150803us-health-menopause-bones-iduskcn0q81tv20150803feedtyperssfeednamehealthnews-reuters">&lt;a href="http://www.reuters.com/article/2015/08/03/us-health-menopause-bones-idUSKCN0Q81TV20150803?feedType=RSS&amp;amp;feedName=healthNews">Vitamin D may not benefit postmenopausal bone health&lt;/a> Reuters&lt;/h3>
&lt;hr>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-osteoporosis-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Osteoporosis and vitamin D">Overview Osteoporosis and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/osteoporosis-treatment-vitamin-d-is-the-most-cost-effective" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019">Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Calcium supplements proven to NOT reduce fractures, but are proven to INCREASE heart problems</title><link>/posts/calcium-supplements-proven-to-not-reduce-fractures-but-are-proven-to-increase-heart-problems.html</link><pubDate>Wed, 15 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/calcium-supplements-proven-to-not-reduce-fractures-but-are-proven-to-increase-heart-problems.html</guid><description/></item><item><title>High dose vitamin reduced pain of fibromyalgia, osteoarthritis, and rheumatoid arthritis</title><link>/posts/high-dose-vitamin-reduced-pain-of-fibromyalgia-osteoarthritis-and-rheumatoid-arthritis.html</link><pubDate>Sat, 11 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/high-dose-vitamin-reduced-pain-of-fibromyalgia-osteoarthritis-and-rheumatoid-arthritis.html</guid><description/></item><item><title>Spectacular improvement in vitamin D status in elderly osteoporotic women</title><link>/posts/spectacular-improvement-in-vitamin-d-status-in-elderly-osteoporotic-women.html</link><pubDate>Wed, 24 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/spectacular-improvement-in-vitamin-d-status-in-elderly-osteoporotic-women.html</guid><description>&lt;h4 id="spectacular-improvement-in-vitamin-d-status-in-elderly-osteoporotic-women-8-year-analysis-of-an-osteoporotic-population-treated-in-a-dedicated-fracture-liaison-service">Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service&lt;/h4>
&lt;p>Osteoporosis International, June 2015&lt;/p>
&lt;p>A.	Amouzougan, A. Deygat, B. Trombert, E. Constant, D. Denarié, H. Marotte, T. Thomas &lt;a href="mailto:thierry.thomas@chu-st-etienne.fr">thierry.thomas@chu-st-etienne.fr&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>Note: this is for women who has osteoporosis.&lt;/p>
&lt;p>Anticipate that many more women no longer have osteoporosis visits due to increased vitamin D.&lt;/p>
&lt;p>      especially those who are not taking excessive Calcium&lt;/p></description></item><item><title>Vitamin D levels increasing 7 percent per year, bones denser in Japan (probably supplementation)</title><link>/posts/vitamin-d-levels-increasing-7-percent-per-year-bones-denser-in-japan-probably-supplementation.html</link><pubDate>Sat, 20 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-increasing-7-percent-per-year-bones-denser-in-japan-probably-supplementation.html</guid><description>&lt;h4 id="factors-affecting-changes-in-the-serum-levels-of-25-hydroxyvitamin-d-a-3-year-follow-up-of-the-road-study">Factors affecting changes in the serum levels of 25-hydroxyvitamin D: a 3-year follow-up of the ROAD study.&lt;/h4>
&lt;p>Osteoporos Int. 2015 Jun 19. DOI: 10.1007/s00198-015-3184-0&lt;/p>
&lt;p>Yoshimura N1, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, Akune T.&lt;/p>
&lt;p>1Department of Joint Disease Research, 22nd Century Medical and Research Center, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan, &lt;a href="mailto:YOSHIMURAN-ORT@h.u-tokyo.ac.jp">YOSHIMURAN-ORT@h.u-tokyo.ac.jp&lt;/a>.&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/road-chart.jpg" alt="image" width="300">
&lt;p>In this 3-year population-based cohort study, among 1346 subjects, the mean annual change in the serum 25-hydroxyvitamin D levels was &lt;strong>7.6 %/year&lt;/strong> , which tended to increase during the 3-year period. Multivariate regression analysis indicated that the L2-4 bone mineral density and total daily energy intake were significant independent associated factors.&lt;/p></description></item><item><title>Osteoporosis groups hide their synthetic vitamin D recommendations behind 40 dollar paywall</title><link>/posts/osteoporosis-groups-hide-their-synthetic-vitamin-d-recommendations-behind-40-dollar-paywall.html</link><pubDate>Sat, 02 May 2015 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-groups-hide-their-synthetic-vitamin-d-recommendations-behind-40-dollar-paywall.html</guid><description/></item><item><title>The role of vitamin D in osteoporosis</title><link>/posts/the-role-of-vitamin-d-in-osteoporosis.html</link><pubDate>Sun, 18 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/the-role-of-vitamin-d-in-osteoporosis.html</guid><description>&lt;p>doi:10.1016/j.maturitas.2014.12.018 online 13 January 2015&lt;/p>
&lt;p>Max Brincata, , Jeannine Gambina, Mark Brincata, Jean Calleja-Agiusa, b, ,&lt;/p>
&lt;h4 id="highlights">Highlights&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Circulating vitamin D predominately arises from synthesis in the skin after exposure to sunlight (ultraviolet B photons with wavelengths between 290 and 315 nm) and should therefore be considered as a hormone.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D deficiency is world-wide epidemic and presents when serum 25 hydroxyvitamin D levels fall below 50 nmol/L.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D deficiency is a factor in the multifactorial causes of non-vertebral &amp;amp; hip fractures, falls and loss of muscles power.&lt;/p></description></item><item><title>Osteoporosis Society UK: 20 ng vitamin D is sufficient, loading dose 300,000 IU</title><link>/posts/osteoporosis-society-uk-20-ng-vitamin-d-is-sufficient-loading-dose-300000-iu.html</link><pubDate>Wed, 17 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-society-uk-20-ng-vitamin-d-is-sufficient-loading-dose-300000-iu.html</guid><description>&lt;h3 id="national-osteoporosis-society-vitamin-d-guideline-summary">National Osteoporosis Society Vitamin D Guideline Summary&lt;/h3>
&lt;p>Age Ageing. 2014;43(5):592-595. © 2014 Oxford University Press&lt;/p>
&lt;p>&lt;a href="http://www.medscape.com/viewarticle/831094_1%20">Medscape&lt;/a>&lt;/p>
&lt;p>Terry J. Aspray, Claire Bowring, William Fraser, Neil Gittoes, M. Kassim Javaid, Helen Macdonald, Sanjeev Patel, Peter Selby, Nuttan Tanna, Roger M. Francis&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:>80%">
&lt;ul>
&lt;li>They appear to have increased the level from their previous publication&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>&lt;a href="/posts/national-osteoporosis-society-of-uk-declares-that-12-ng-of-vitamin-d-is-enough">National Osteoporosis Society of UK declares that 12 ng of vitamin D is enough – June 2013&lt;/a>&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>
&lt;p>They recommend the lowest vitamin D levels in the world (20 ng vs 30-50 ng)&lt;/p></description></item><item><title>Vitamin D can quickly deal with Osteoporosis in the very old – Europe working group review</title><link>/posts/vitamin-d-can-quickly-deal-with-osteoporosis-in-the-very-old-europe-working-group-review.html</link><pubDate>Wed, 16 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-can-quickly-deal-with-osteoporosis-in-the-very-old-europe-working-group-review.html</guid><description>&lt;h2 id="management-of-osteoporosis-of-the-oldest-old">Management of osteoporosis of the oldest old.&lt;/h2>
&lt;p>Osteoporos Int. 2014 Jul 15. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Rizzoli R1, Branco J, Brandi ML, Boonen S, Bruyère O, Cacoub P, Cooper C, Diez-Perez A, Duder J, Fielding RA, Harvey NC, Hiligsmann M, Kanis JA, Petermans J, Ringe JD, Tsouderos Y, Weinman J, Reginster JY.&lt;/p>
&lt;p>1Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland, &lt;a href="mailto:Rene.Rizzoli@unige.ch">Rene.Rizzoli@unige.ch&lt;/a>.&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#management-of-osteoporosis-of-the-oldest-old">Management of osteoporosis of the oldest old.&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>This consensus article reviews the diagnosis and treatment of osteoporosis in geriatric populations. Specifically, it reviews the risk assessment and intervention thresholds, the impact of nutritional deficiencies, fall prevention strategies, pharmacological treatments and their safety considerations, the risks of sub-optimal treatment adherence and strategies for its improvement.&lt;/p></description></item><item><title>Virtually all vitamin D testing not associated with a symptom, but 10 percent had osteoporosis</title><link>/posts/virtually-all-vitamin-d-testing-not-associated-with-a-symptom-but-10-percent-had-osteoporosis.html</link><pubDate>Wed, 09 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/virtually-all-vitamin-d-testing-not-associated-with-a-symptom-but-10-percent-had-osteoporosis.html</guid><description>&lt;h3 id="surge-in-us-outpatient-vitamin-d-deficiency-diagnoses-national-ambulatory-medical-care-survey-analysis">Surge in US Outpatient Vitamin D Deficiency Diagnoses: National Ambulatory Medical Care Survey Analysis.&lt;/h3>
&lt;p>South Med J. 2014 Apr;107(4):214-7. &lt;a href="https://doi.org/10.1097/SMJ.0000000000000085.">doi: 10.1097/SMJ.0000000000000085.&lt;/a>&lt;/p>
&lt;p>Huang KE, Milliron BJ, Davis SA, Feldman SR.&lt;/p>
&lt;p>From the Departments of Dermatology, Public Health Sciences, Pathology, andSocial Sciences and Health Policy, Center for Dermatology Research, Wake Forest School of Medicine; Winston-Salem, North Carolina.&lt;/p>
&lt;p>OBJECTIVES:&lt;/p>
&lt;p>In light of the growing medical interest in the potential consequences of vitamin D deficiency, it is important that clinicians are informed about the varying factors that may complicate the assessment of vitamin D status and the diagnosis of deficiency. To better understand the frequency of vitamin D deficiency diagnoses in the ambulatory setting over time, the objective of this investigation was to examine unspecific, general, and bone-related vitamin D deficiency diagnoses between 2007 and 2010 and to determine whether the rate of diagnoses differed by patient age and sex.&lt;/p></description></item><item><title>Magnesium Reduces Osteoporosis - Infographic</title><link>/posts/magnesium-reduces-osteoporosis-infographic.html</link><pubDate>Tue, 24 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/magnesium-reduces-osteoporosis-infographic.html</guid><description/></item><item><title>Hypothesis: Vitamin D is the link between Osteoporosis, Obesity, and Diabetes</title><link>/posts/hypothesis-vitamin-d-is-the-link-between-osteoporosis-obesity-and-diabetes.html</link><pubDate>Thu, 17 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-vitamin-d-is-the-link-between-osteoporosis-obesity-and-diabetes.html</guid><description>&lt;h3 id="vitamin-d-link-between-osteoporosis-obesity-and-diabetes">Vitamin D: Link between Osteoporosis, Obesity, and Diabetes?&lt;/h3>
&lt;p>Int. J. Mol. Sci. 2014, 15(4), 6569-6591; doi:10.3390/ijms15046569 (doi registration under processing)&lt;/p>
&lt;p>Flávia Galvão Cândido &lt;a href="mailto:flaviagcandido@hotmail.com">flaviagcandido@hotmail.com&lt;/a> and Josefina Bressan&lt;/p>
&lt;p>Laboratory of Body Composition and Energy Metabolism, Departamento de Nutrição e Saúde-CCB II, Universidade Federal de Viçosa, Avenida PH Rolfs, s/n, Viçosa, MG 36570-900, Brazil&lt;/p>
&lt;p>(This article belongs to the Section Bioactives and Nutraceuticals)&lt;/p>
&lt;p>Vitamin D (1,25(OH)2D3) is a steroid hormone that has a range of physiological functions in skeletal and nonskeletal tissues, and can contribute to prevent and/or treat osteoporosis, obesity, and Type 2 diabetes mellitus (T2DM). In bone metabolism, vitamin D increases the plasma levels of calcium and phosphorus, regulates osteoblast and osteoclast the activity, and combats PTH hypersecretion, promoting bone formation and preventing/treating osteoporosis. This evidence is supported by most clinical studies, especially those that have included calcium and assessed the effects of vitamin D doses (≥800 IU/day) on bone mineral density. However, annual megadoses should be avoided as they impair bone health.&lt;/p></description></item><item><title>Fractures reduced with any amount of vitamin D and some Calcium - Cochraine</title><link>/posts/fractures-reduced-with-any-amount-of-vitamin-d-and-some-calcium-cochraine.html</link><pubDate>Mon, 14 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/fractures-reduced-with-any-amount-of-vitamin-d-and-some-calcium-cochraine.html</guid><description>&lt;h4 id="cochraine-like-many-other-meta-groups-ignores-dose-size-so-the-majority-of-studies-which-use-400-iu-cancel-out-the-benefits-from-studies-using-10x-as-much">Cochraine, like many other meta-groups, ignores dose size, so the majority of studies which use 400 IU cancel out the benefits from studies using 10X as much&lt;/h4>
&lt;p>&lt;strong>They also ignore the importance of Magnesium, Boron, and Silicone in building strong bones.&lt;/strong>&lt;/p>
&lt;h4 id="they-probably-also-wrongly-assume-that-the-increase-bone-mineral-density-bmd-results-in-increase-in-bone-strength">They probably also (wrongly) assume that the increase Bone Mineral Density (BMD) results in increase in Bone Strength.&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/osteo-hip-joint.jpg" alt="image">
&lt;hr>
&lt;h4 id="vitamin-d-and-related-vitamin-d-compounds-for-preventing-fractures-resulting-from-osteoporosis-in-older-people-updated">Vitamin D and related vitamin D compounds for preventing fractures resulting from osteoporosis in older people Updated&lt;/h4>
&lt;p>Avenell A, Mak JCS, O&amp;rsquo;Connell D&lt;/p></description></item><item><title>Hypothesis- Metabolic disease is due to Tissue Renin-Angiotensin Systems</title><link>/posts/hypothesis-metabolic-disease-is-due-to-tissue-renin-angiotensin-systems.html</link><pubDate>Wed, 05 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-metabolic-disease-is-due-to-tissue-renin-angiotensin-systems.html</guid><description>&lt;h3 id="tissue-renin-angiotensin-systems-a-unifying-hypothesis-of-metabolic-disease">Tissue Renin-Angiotensin Systems: A Unifying Hypothesis of Metabolic Disease.&lt;/h3>
&lt;p>Front Endocrinol (Lausanne). 2014 Feb 28;5:23. eCollection 2014.&lt;/p>
&lt;p>Skov J 1, Persson F 2, Frøkiær J 3, Christiansen JS 4.&lt;/p>
&lt;p>1Department of Endocrinology and Internal Medicine, Aarhus University Hospital , Aarhus , Denmark ; Novo Nordisk A/S , Bagsvaerd , Denmark.&lt;/p>
&lt;p>2Steno Diabetes Center , Gentofte , Denmark.&lt;/p>
&lt;p>3Department of Clinical Physiology and Molecular Imaging, Aarhus University Hospital , Aarhus , Denmark ; Department of Clinical Medicine, Aarhus University , Aarhus , Denmark.&lt;/p></description></item><item><title>Osteoporosis quality of life better if more than 20 ng of vitamin D</title><link>/posts/osteoporosis-quality-of-life-better-if-more-than-20-ng-of-vitamin-d.html</link><pubDate>Tue, 28 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-quality-of-life-better-if-more-than-20-ng-of-vitamin-d.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-level-as-an-independent-determinant-of-quality-of-life-in-osteoporosis-with-a-high-risk-for-fracture">Serum 25-Hydroxyvitamin D Level as an Independent Determinant of Quality of Life in Osteoporosis With a High Risk for Fracture☆&lt;/h4>
&lt;p>Hiroaki Ohta, MD, PhD, Yukari Uemura, PhD, Toshitaka Nakamura, MD, PhD, Masao Fukunaga, MD, PhD, Yasuo Ohashi, PhD, Takayuki Hosoi, MD, PhD, Satoshi Mori, MD, PhD, Toshitsugu Sugimoto, MD, PhD, Eiji Itoi, MD, PhD, Hajime Orimo, MD, PhD, Masataka Shiraki, MD, PhDemail address, for the Adequate Treatment of Osteoporosis (A-TOP) Research Group&lt;/p></description></item><item><title>20X increase in vitamin D sold and 36 percent decrease in osteoporosis business in Australia</title><link>/posts/20x-increase-in-vitamin-d-sold-and-36-percent-decrease-in-osteoporosis-business-in-australia.html</link><pubDate>Tue, 26 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/20x-increase-in-vitamin-d-sold-and-36-percent-decrease-in-osteoporosis-business-in-australia.html</guid><description>&lt;p>&lt;strong>Wonder how many other medical interactions/costs also decreased in Australia due to the huge increase in vitamin D&lt;/strong>&lt;/p>
&lt;p>&lt;strong>It appears that the wholesale cost of the 3kg of vitamin D (for the entire country of Australia) is less than $100,000&lt;/strong>&lt;/p></description></item><item><title>Osteoporosis due to antiepileptic drugs: placebo including Vitamin D helped 69 percent, placebo with risedronate helped 70%</title><link>/posts/osteoporosis-due-to-antiepileptic-drugs-placebo-including-vitamin-d-helped-69-pe-lped-70-percent.html</link><pubDate>Fri, 08 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-due-to-antiepileptic-drugs-placebo-including-vitamin-d-helped-69-pe-lped-70-percent.html</guid><description>&lt;h4 id="prevention-of-bone-loss-and-vertebral-fractures-in-patients-with-chronic-epilepsy-antiepileptic-drug-and-osteoporosis-prevention-trial">Prevention of bone loss and vertebral fractures in patients with chronic epilepsy-Antiepileptic drug and osteoporosis prevention trial.&lt;/h4>
&lt;p>Epilepsia. 2013 Sep 6. &lt;a href="https://doi.org/10.1111/epi.12351.">doi: 10.1111/epi.12351.&lt;/a>&lt;/p>
&lt;p>Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.&lt;/p>
&lt;p>Primary Care Service, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Osteoporosis Clinic, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Rheumatology Section, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Department of Medicine, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, U.S.A; Department of Medicine, Harvard Medical School, Boston, Massachusetts, U.S.A.&lt;/p></description></item><item><title>Safety profile of Osteoporosis drugs, including vitamin D – review</title><link>/posts/safety-profile-of-osteoporosis-drugs-including-vitamin-d-review.html</link><pubDate>Thu, 07 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/safety-profile-of-osteoporosis-drugs-including-vitamin-d-review.html</guid><description>&lt;p>Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature.&lt;/p>
&lt;p>Reumatismo. 2013 Oct 31;65(4):143-66. &lt;a href="https://doi.org/10.4081/reumatismo.2013.143.">doi: 10.4081/reumatismo.2013.143.&lt;/a>&lt;/p>
&lt;p>Varenna M, Bertoldo F, Di Monaco M, Giusti A, Martini G, Rossini M, Siommms OB, Sir EB.&lt;/p>
&lt;p>Bone Diseases Unit, Department of Rheumatology, Gaetano Pini Institute, Milan. &lt;a href="mailto:varenna@gpini.it">varenna@gpini.it&lt;/a>.&lt;/p>
&lt;p>The range of osteoporosis treatments is increasingly large and, like any disease, the pharmacological management of patients should involve a risk/benefit evaluation to attain the greatest reduction in risk of fracture with the lowest incidence of adverse events. The aim of this review is to critically appraise the literature about the safety issues of the main pharmacological treatments of osteoporosis. This document is the result of a consensus of experts based on a systematic review of regulatory documents, randomized controlled trials, metaanalyses, pharmacovigilance surveys and case series related to possible adverse drug reactions to osteoporosis treatment with calcium and vitamin D supplements, bisphosphonates, strontium ranelate, selective estrogen receptor modulators, denosumab, and teriparatide. As expected, randomized controlled trials showed only the most common adverse events due to the samples size and the short observation time. Case series and observational studies are able to provide data about uncommon side effects, but in some cases a sure cause-effect relationship needs still to be confirmed. Consistently with methodological limitations, the newer drugs have a tolerance profile that has not been fully explored yet. Osteoporosis treatments showed an overall good tolerance profile with rare serious adverse events that, however, must be well known by the clinician who prescribes these drugs. The concern about possible adverse events should be weighed against the reduction of morbidity and mortality associated with a significant fracture risk reduction.&lt;/p></description></item><item><title>World Osteoporosis Day sponsored by Big Pharma – does not give good sun or vitamin D info</title><link>/posts/world-osteoporosis-day-sponsored-by-big-pharma-does-not-give-good-sun-or-vitamin-d-info.html</link><pubDate>Mon, 21 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/world-osteoporosis-day-sponsored-by-big-pharma-does-not-give-good-sun-or-vitamin-d-info.html</guid><description/></item><item><title>Vitamin D and Bone Health – UK National Osteoporosis Society</title><link>/posts/vitamin-d-and-bone-health-uk-national-osteoporosis-society.html</link><pubDate>Sat, 19 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-bone-health-uk-national-osteoporosis-society.html</guid><description>&lt;h4 id="vitamin-d-and-bone-health-a-practical-clinical-guideline-for-patient-management">Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management&lt;/h4>
&lt;p>There is growing interest in the importance of vitamin D, not only in the maintenance of bone health but also in terms of its potential role in the prevention of nonskeletal disorders such as auto-immune disease, cancer, mental health problems and cardiovascular disease. Although there is no universal consensus on the criteria for vitamin D deficiency, it is common in the UK, particularly in older people. The awareness that vitamin D deficiency may contribute to the development of osteoporosis and to falls and fractures has resulted in a dramatic increase in requests for serum 25 hydroxyvitamin D (25OHD) measurements. The lack of national guidance on the indications for 25OHD measurements, on the interpretation of the results and on the correction of vitamin D deficiency has resulted in confusion among patients and health-care professionals and in the proliferation of conflicting guidelines and inconsistent practice across the UK. As a result, the National Osteoporosis Society has developed this practical clinical guideline on the management of vitamin D deficiency in adult patients with, or at risk of developing, bone disease. This guideline does not address the management of vitamin D deficiency in childhood, in pregnancy or in patients with severe or end-stage chronic kidney disease (CKD Stages 4-5).&lt;/p></description></item><item><title>During brown bear hibernation Vitamin D3 decreases but D2 increases (surprise)</title><link>/posts/during-brown-bear-hibernation-vitamin-d3-decreases-but-d2-increases-surprise.html</link><pubDate>Mon, 14 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/during-brown-bear-hibernation-vitamin-d3-decreases-but-d2-increases-surprise.html</guid><description>&lt;h3 id="vitamin-d-status-and-bone-and-connective-tissue-turnover-in-brown-bears-ursus-arctos-during-hibernation-and-the-active-state">Vitamin D Status and Bone and Connective Tissue Turnover in Brown Bears (Ursus arctos) during Hibernation and the Active State&lt;/h3>
&lt;p>PLoS ONE 6(6): e21483. doi:10.1371/journal.pone.0021483&lt;/p>
&lt;p>Peter Vestergaard mail, Ole-Gunnar Støen, Jon E. Swenson, Leif Mosekilde, Lene Heickendorff, Ole Fröbert&lt;/p>
&lt;p>Background: Extended physical inactivity causes disuse osteoporosis in humans. In contrast, brown bears (Ursus arctos) are highly immobilised for half of the year during hibernation without signs of bone loss and therefore may serve as a model for prevention of osteoporosis.&lt;/p></description></item><item><title>Yet again, 800 IU of vitamin D was found to be barely enough to help bones – Lancet</title><link>/posts/yet-again-800-iu-of-vitamin-d-was-found-to-be-barely-enough-to-help-bones-lancet.html</link><pubDate>Fri, 11 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/yet-again-800-iu-of-vitamin-d-was-found-to-be-barely-enough-to-help-bones-lancet.html</guid><description>&lt;h2 id="the-study">The study:&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>Ignored how much vitamin D was given - most of the studies used &amp;lt; 800 IU.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Ignored if vitamin D2 vs Vitamin &lt;strong>&lt;span style="color:#00F;">D3&lt;/span>&lt;/strong> was used - Vitamin D2 has far less benefit, and sometimes decreases the D3 levels&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Ignored how often the vitamin D dose was given - they included studies which used annual doses&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Ignored if Calcium or other cofactors were given&lt;/p>
&lt;ul>
&lt;li>&lt;strong>Only 5 of the 23 studies used &amp;gt;800 IU of vitamin D3 with Calcium&lt;/strong>&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>6 studies actually found a benefit&lt;/strong>&lt;/p></description></item><item><title>Vitamin K and bone health – need more research</title><link>/posts/vitamin-k-and-bone-health-need-more-research.html</link><pubDate>Sun, 06 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-k-and-bone-health-need-more-research.html</guid><description>&lt;h4 id="vitamin-k-and-bone-health">Vitamin K and bone health&lt;/h4>
&lt;p>Journal of Clinical Densitometry&lt;/p>
&lt;p>Maryam S. Hamidi1,&lt;/p>
&lt;p>Olga Gajic-Veljanoski1,&lt;/p>
&lt;p>Angela M. Cheung1, 2, &lt;a href="mailto:angela.m.cheung@gmail.com">angela.m.cheung@gmail.com&lt;/a>&lt;/p>
&lt;p>1 Osteoporosis and Women&amp;rsquo;s Health Programs at University Health Network, Toronto, ON, Canada&lt;/p>
&lt;p>2 Department of Medicine at University of Toronto, Toronto, ON, Canada&lt;/p>
&lt;p>Vitamin K has been purported to play an important role in bone health. It is required for the gamma-carboxylation of osteocalcin (the most abundant noncollagenous protein in bone), making osteocalcin functional.&lt;/p></description></item><item><title>Both Vitamin D and Calcium are needed to reduce bone loss – RCT</title><link>/posts/both-vitamin-d-and-calcium-are-needed-to-reduce-bone-loss-rct.html</link><pubDate>Tue, 24 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/both-vitamin-d-and-calcium-are-needed-to-reduce-bone-loss-rct.html</guid><description>&lt;h3 id="calcium-and-vitamin-d-supplementation-in-postmenopausal-women">Calcium and Vitamin D Supplementation in Postmenopausal Women&lt;/h3>
&lt;p>The Journal of Clinical Endocrinology &amp;amp; Metabolism September 24, 2013 jc.2013-2121&lt;/p>
&lt;p>John F. Aloia, Ruban Dhaliwal, Albert Shieh, Mageda Mikhail, Shahidul Islam and James K. Yeh&lt;/p>
&lt;p>Winthrop University Hospital, Bone Mineral Research Center, Mineola, New York 11501&lt;/p>
&lt;p>Address all correspondence and requests for reprints to: John F. Aloia, MD, Winthrop University Hospital, 222 Station Plaza North, Suite 510, Mineola, New York 11501. E-mail: &lt;a href="mailto:jaloia@winthrop.org">jaloia@winthrop.org&lt;/a>.&lt;/p></description></item><item><title>Causes, consequences, and treatment of osteoporosis in men</title><link>/posts/causes-consequences-and-treatment-of-osteoporosis-in-men.html</link><pubDate>Tue, 10 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/causes-consequences-and-treatment-of-osteoporosis-in-men.html</guid><description>&lt;p>Drug Des Devel Ther. 2013 Aug 22;7:849-860.&lt;/p>
&lt;p>Banu J.&lt;/p>
&lt;p>Coordinated Program in Dietetics, College of Health Sciences and Human Services and Department of Biology, College of Science and Mathematics, University of Texas-Pan American, Edinburg, TX, USA.&lt;/p>
&lt;p>Men undergo gradual bone loss with aging, resulting in fragile bones. It is estimated that one in five men will suffer an osteoporotic fracture during their lifetime.&lt;/p>
&lt;p>The prognosis for men after a hip fracture is very grim.&lt;/p></description></item><item><title>Osteoporosis 2.8 X more likely if Vitamin D receptor (VDR) genes altered</title><link>/posts/osteoporosis-28-x-more-likely-if-vitamin-d-receptor-vdr-genes-altered.html</link><pubDate>Tue, 27 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-28-x-more-likely-if-vitamin-d-receptor-vdr-genes-altered.html</guid><description>&lt;h4 id="vitamin-d-receptor-vdr-gene-polymorphism-influences-the-risk-of-osteoporosis-in-postmenopausal-women-of-northwest-india">Vitamin D receptor (VDR) gene polymorphism influences the risk of osteoporosis in postmenopausal women of Northwest India.&lt;/h4>
&lt;p>Arch Osteoporos. 2013 Dec;8(1-2):147. &lt;a href="https://doi.org/10.1007/s11657-013-0147-y.">doi: 10.1007/s11657-013-0147-y.&lt;/a> Epub 2013 Aug 22.&lt;/p>
&lt;p>Singh M, Singh P, Singh S, Juneja PK, Kaur T.&lt;/p>
&lt;p>Molecular Genetics Laboratory, Department of Human Genetics, Punjabi University, Patiala, Punjab, India.&lt;/p>
&lt;p>Abstract: The influence of VDR gene for the risk of osteoporosis has remained inconclusive.&lt;/p>
&lt;p>VDR gene polymorphism in relation to BMD in postmenopausal women of Northwest India revealed a susceptibility haplotype AGT.&lt;/p></description></item><item><title>Osteoporosis: Diagnosis and Management (professional book)</title><link>/posts/osteoporosis-diagnosis-and-management-professional-book.html</link><pubDate>Sun, 25 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-diagnosis-and-management-professional-book.html</guid><description>&lt;p>Dale W. Stovall (Editor) Amazon&lt;/p>
&lt;p>$117.61 Vitamin D mentioned 46 times&lt;/p>
&lt;p>VitaminDWiki has not seen it&lt;/p></description></item><item><title>22 percent more bone cracking found with low vitamin D</title><link>/posts/22-percent-more-bone-cracking-found-with-low-vitamin-d.html</link><pubDate>Thu, 11 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/22-percent-more-bone-cracking-found-with-low-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-deficiency-induces-early-signs-of-aging-in-human-bone-increasing-the-risk-of-fracture">Vitamin D Deficiency Induces Early Signs of Aging in Human Bone, Increasing the Risk of Fracture&lt;/h3>
&lt;p>Sci Transl Med 10 July 2013: Vol. 5, Issue 193, p. 193ra88&lt;/p>
&lt;p>Björn Busse 1,2, &lt;a href="mailto:b.busse@uke.uni-hamburg.de">b.busse@uke.uni-hamburg.de&lt;/a>&lt;/p>
&lt;p>Hrishikesh A. Bale 2,&lt;/p>
&lt;p>Elizabeth A. Zimmermann 1,2,3,&lt;/p>
&lt;p>Brian Panganiban 2,&lt;/p>
&lt;p>Holly D. Barth 2,3,&lt;/p>
&lt;p>Alessandra Carriero 2,&lt;/p>
&lt;p>Eik Vettorazzi 4,&lt;/p>
&lt;p>Josef Zustin 5,&lt;/p>
&lt;p>Michael Hahn 1,&lt;/p>
&lt;p>Joel W. Ager III 2,&lt;/p>
&lt;p>Klaus Püschel 6,&lt;/p>
&lt;p>Michael Amling 1 and&lt;/p></description></item><item><title>National Osteoporosis Society of UK declares that 12 ng of vitamin D is enough</title><link>/posts/national-osteoporosis-society-of-uk-declares-that-12-ng-of-vitamin-d-is-enough.html</link><pubDate>Fri, 21 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/national-osteoporosis-society-of-uk-declares-that-12-ng-of-vitamin-d-is-enough.html</guid><description/></item><item><title>4X increase in osteoporosis visits, but vitamin D information is still not available</title><link>/posts/4x-increase-in-osteoporosis-visits-but-vitamin-d-information-is-still-not-available.html</link><pubDate>Fri, 31 May 2013 00:00:00 +0000</pubDate><guid>/posts/4x-increase-in-osteoporosis-visits-but-vitamin-d-information-is-still-not-available.html</guid><description>&lt;h2 id="changing-trends-in-osteoporosis-care-from-specialty-to-primary-care-physicians">Changing trends in osteoporosis care from specialty to primary care physicians.&lt;/h2>
&lt;p>Curr Med Res Opin. 2013 May 29.&lt;/p>
&lt;p>Rianon N, Anand D, Rasu R.&lt;/p>
&lt;p>University of Texas Medical School at Houston, Houston TX USA.&lt;/p>
&lt;p>Background: Inadequate treatment by non-specialty primary care physicians (PCPs) has been a concern in improving osteoporosis care. An increase in outpatient visits by older patients seeking osteoporosis care has been reported. But what percentages of these visits are made to PCPs are unknown. We investigated recent trends of outpatient visits and treatment for osteoporosis in older adults (&amp;gt; 50 years) by physician type (PCPs vs. specialty care non-PCPs). Methods: Cross-sectional analysis used National Hospital Ambulatory Medical Care Survey (NHAMCS) data from 2002-2008 in the USA. Patients ≥ 50years with osteoporosis were included. Descriptive and logistic analysis reported trends of visits and treatment for osteoporosis care by physician type.&lt;/p></description></item><item><title>8X higher Osteoporosis risk if high level of vitamin A, vitamin D important too</title><link>/posts/8x-higher-osteoporosis-risk-if-high-level-of-vitamin-a-vitamin-d-important-too.html</link><pubDate>Tue, 19 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/8x-higher-osteoporosis-risk-if-high-level-of-vitamin-a-vitamin-d-important-too.html</guid><description>&lt;h2 id="vitamin-d-insufficiency-together-with-high-serum-levels-of-vitamin-a-increases-the-risk-for-osteoporosis-in-postmenopausal-women">Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women.&lt;/h2>
&lt;p>Arch Osteoporos. 2013 Dec;8(1-2):124. Epub 2013 Feb 16.&lt;/p>
&lt;p>Mata-Granados JM, Cuenca-Acevedo JR, Luque de Castro MD, Holick MF, Quesada-Gómez JM.&lt;/p>
&lt;p>Department of I+D+I, Sanyres Group, Córdoba, Spain.&lt;/p>
&lt;p>Postmenopausal women who were vitamin D deficient and had high serum levels of retinol had an eight times higher risk of having osteoporosis.&lt;/p>
&lt;p>A high retinol level together with vitamin D deficiency/insufficiency is an additional risk factor for osteoporosis.&lt;/p></description></item><item><title>Osteoporosis spot therapies: vitamin D with Calcium was the most popular</title><link>/posts/osteoporosis-spot-therapies-vitamin-d-with-calcium-was-the-most-popular.html</link><pubDate>Thu, 14 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-spot-therapies-vitamin-d-with-calcium-was-the-most-popular.html</guid><description>&lt;h2 id="adherence-to-anti-osteoporotic-therapies-role-and-determinants-of-spot-therapy">Adherence to anti-osteoporotic therapies: role and determinants of &amp;ldquo;spot therapy&amp;rdquo;&lt;/h2>
&lt;p>Osteoporos Int. 2013 Feb 12.&lt;/p>
&lt;p>Tafaro L, Nati G, Leoni E, Baldini R, Cattaruzza MS, Mei M, Falaschi P.&lt;/p>
&lt;p>Geriatric Unit, Sant&amp;rsquo;Andrea Hospital, Sapienza University of Rome, via di Grottarossa No. 1035, 00189, Rome, Italy.&lt;/p>
&lt;p>A successful therapy needs high level of adherence consisting in right drug intake in terms of persistence and compliance. Our study suggests adherence is higher if spot (less than 30 days) therapies are excluded; the analysis of spot therapy causes underlines the importance of the interpersonal aspects of medical practice.&lt;/p></description></item><item><title>3D images of bone plus position statements on Osteo and vitamin D – 2012</title><link>/posts/3d-images-of-bone-plus-position-statements-on-osteo-and-vitamin-d-2012.html</link><pubDate>Thu, 17 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/3d-images-of-bone-plus-position-statements-on-osteo-and-vitamin-d-2012.html</guid><description>&lt;p>The following is a fraction of &lt;strong>The fragile beauty of bone architecture&lt;/strong> published in Medicographia&lt;/p>
&lt;p>Louis-Georges STE-MARIE,MD&lt;/p>
&lt;p>Natalie DION PhD&lt;/p>
&lt;p>Centre Hospitalier de l’Université de Montréal&lt;/p>
&lt;p>Université de Montréal – Montréal, CANADA&lt;/p>
&lt;hr>
&lt;p>&lt;strong>The full issue of Medicographia, which includes the article: CONTROVERSIAL QUESTION, Is systematic supplementation with calcium/vitamin D necessary to treat postmenopausal osteoporosis? Is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;hr>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/3d-bone.jpg" alt="image">
&lt;h2 id="figure-2-structural-impairment-in-bone-disease">Figure 2. Structural impairment in bone disease.&lt;/h2>
&lt;p>Undecalcified bone biopsies (3D microcomputed tomography or 2D microscopic histology &lt;span>[Goldner’s stain]&lt;/span>).&lt;/p></description></item><item><title>European Osteo group recommends 20-50 ng of vitamin D</title><link>/posts/european-osteo-group-recommends-20-50-ng-of-vitamin-d.html</link><pubDate>Thu, 17 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/european-osteo-group-recommends-20-50-ng-of-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-supplementation-in-elderly-or-postmenopausal-women">Vitamin D supplementation in elderly or postmenopausal women:&lt;/h2>
&lt;h3 id="a-2013-update-of-the-2008-recommendations-from-the-european-society-for-clinical-and-economic-aspects-of-osteoporosis-and-osteoarthritis-esceo">A 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).&lt;/h3>
&lt;p>Curr Med Res Opin. 2013 Jan 15.&lt;/p>
&lt;p>Rizzoli R, Boonen S, Brandi ML, Bruyère O, Cooper C, Kanis JA, Kaufman JM, Ringe JD, Weryha G, Reginster J.&lt;/p>
&lt;p>Background Vitamin D insufficiency has deleterious consequences on health outcomes. In elderly or postmenopausal women, it may exacerbate osteoporosis.&lt;/p></description></item><item><title>Low Vitamin D or Vitamin K2 may be a cause of Hypertension and Osteoporosis</title><link>/posts/low-vitamin-d-or-vitamin-k2-may-be-a-cause-of-hypertension-and-osteoporosis.html</link><pubDate>Fri, 30 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-or-vitamin-k2-may-be-a-cause-of-hypertension-and-osteoporosis.html</guid><description/></item><item><title>Vitamin D Receptor genes bb and BB and Osteoporosis, esp. for blacks – meta-analysis</title><link>/posts/vitamin-d-receptor-genes-bb-and-bb-and-osteoporosis-esp-for-blacks-meta-analysis.html</link><pubDate>Fri, 30 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-genes-bb-and-bb-and-osteoporosis-esp-for-blacks-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-receptor-bsmi-polymorphism-and-osteoporosis-risk-a-meta-analysis-from-26-studies">Vitamin D Receptor BsmI Polymorphism and Osteoporosis Risk: A Meta-Analysis from 26 Studies&lt;/h4>
&lt;p>Genetic Testing and Molecular Biomarkers – Nov 2012&lt;/p>
&lt;p>Rui-Fen Sun,2,* Qun-Hui Li,1 Da-Xing Wang,1 Feng Zhao,1 Jun-Min Li,1 Qi Pu,1 Zhong-Zi Zhang,1 Yan Jin,1 Bai-Lian Liu,1 and Ying Xiong1&lt;/p>
&lt;p>1 Department of Orthopedics, Kunming Medical University, National Clinical Key Specialty, Yanan Hospital, Kunming, People&amp;rsquo;s Republic of China.&lt;/p>
&lt;p>2 Central Laboratory, Yunnan University of Chinese Traditional Medicine, Kunming, People&amp;rsquo;s Republic of China.&lt;/p></description></item><item><title>Korea proposes vitamin D of 20 ng, but notes 20ng increases osteo by 50 percent</title><link>/posts/korea-proposes-vitamin-d-of-20-ng-but-notes-20ng-increases-osteo-by-50-percent.html</link><pubDate>Wed, 28 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/korea-proposes-vitamin-d-of-20-ng-but-notes-20ng-increases-osteo-by-50-percent.html</guid><description>&lt;h4 id="see-optimal-serum-concentration-of-25-hydroxyvitamin-d-for-bone-health-in-older-korean-adultshttpwwwncbinlmnihgovpubmed23179104doptabstract-pubmed">See &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/23179104?dopt=Abstract">Optimal Serum Concentration of 25-Hydroxyvitamin D for Bone Health in Older Korean Adults&lt;/a> PubMed&lt;/h4>
&lt;hr>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/9x-increase-in-koreans-seeking-help-with-vitamin-d-deficiency-in-just-4-years">9X increase in Koreans seeking help with vitamin D deficiency in just 4 years – Jan 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-levels-continue-to-fall-in-korea" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D levels continue to fall in Korea– June 2018">Vitamin D levels continue to fall in Korea– June 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/south-koreans-half-take-supplements-vitamin-d-levels-dropping-covid-19" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: South Koreans - half take supplements, Vitamin D levels dropping, COVID-19">South Koreans - half take supplements, Vitamin D levels dropping, COVID-19&lt;/a>&lt;/p></description></item><item><title>Vitamin D was not a predictor of osteoporosis fractures</title><link>/posts/vitamin-d-was-not-a-predictor-of-osteoporosis-fractures.html</link><pubDate>Thu, 11 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-was-not-a-predictor-of-osteoporosis-fractures.html</guid><description/></item><item><title>Hip fracture and vitamin D – Health ABC study</title><link>/posts/hip-fracture-and-vitamin-d-health-abc-study.html</link><pubDate>Fri, 28 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/hip-fracture-and-vitamin-d-health-abc-study.html</guid><description>&lt;h1 id="calciotropic-hormones-and-the-risk-of-hip-and-nonspine-fractures-in-older-adults">Calciotropic hormones and the risk of hip and nonspine fractures in older adults:&lt;/h1>
&lt;h2 id="the-health-abc-study">the Health ABC Study.&lt;/h2>
&lt;p>J Bone Miner Res. 2012 May;27(5):1177-85. &lt;a href="https://doi.org/10.1002/jbmr.1545.">doi: 10.1002/jbmr.1545.&lt;/a>&lt;/p>
&lt;p>Barbour KE, Houston DK, Cummings SR, Boudreau R, Prasad T, Sheu Y, Bauer DC, Tooze JA, Kritchevsky SB, Tylavsky FA, Harris TB, Cauley JA; Health ABC Study.&lt;/p>
&lt;p>Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA. &lt;a href="mailto:barbourk@edc.pitt.edu">barbourk@edc.pitt.edu&lt;/a>&lt;/p>
&lt;p>The effects of vitamin D and parathyroid hormone (PTH) levels on incident fracture remain uncertain.&lt;/p></description></item><item><title>Osteoporosis medicine teriparatide increased active vitamin D by 25 pcnt– RCT</title><link>/posts/osteoporosis-medicine-teriparatide-increased-active-vitamin-d-by-25-pcnt-rct.html</link><pubDate>Sat, 15 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-medicine-teriparatide-increased-active-vitamin-d-by-25-pcnt-rct.html</guid><description>&lt;h1 id="changes-in-vitamin-d-metabolites-during-teriparatide-treatment">Changes in vitamin D metabolites during teriparatide treatment.&lt;/h1>
&lt;p>Bone. 2012 Jun;50(6):1368-71. Epub 2012 Mar 9.&lt;/p>
&lt;p>Cosman F, Dawson-Hughes B, Wan X, Krege JH.&lt;/p>
&lt;p>Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA. &lt;a href="mailto:cosmanf@helenhayeshosp.org">cosmanf@helenhayeshosp.org&lt;/a>&lt;/p>
&lt;p>Parathyroid hormone (PTH) increases the conversion of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> to 1,25 dihydroxyvitamin D &lt;span>[1,25(OH)(2)D]&lt;/span>. The purpose of this study was to assess the changes in serum concentration of vitamin D metabolites 1,25 dihydroxyvitamin D &lt;span>[1,25(OH)(2)D]&lt;/span> and 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> during teriparatide 20 ?g/day (teriparatide) therapy in the double-blind Fracture Prevention Trial of postmenopausal women with osteoporosis and in the male study of men with osteoporosis.&lt;/p></description></item><item><title>HIV leads to low vitamin D which leads to osteoporosis – a growing problem</title><link>/posts/hiv-leads-to-low-vitamin-d-which-leads-to-osteoporosis-a-growing-problem.html</link><pubDate>Fri, 24 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/hiv-leads-to-low-vitamin-d-which-leads-to-osteoporosis-a-growing-problem.html</guid><description>&lt;h4 id="osteoporosis-in-persons-with-hiv-a-future-epidemic">Osteoporosis in persons with HIV: a future epidemic?&lt;/h4>
&lt;p>J La State Med Soc. 2012 May-Jun;164(3):127-30.&lt;/p>
&lt;p>Clark R.&lt;/p>
&lt;p>Louisiana State University Health Sciences Center, New Orleans, USA.&lt;/p>
&lt;p>Given the aging of the American population with human immunodeficiency virus (HIV) and the high prevalence of suboptimal 25(OH)D (vitamin D) levels, osteoporosis is likely to be a growing concern among clinicians caring for this population. HIV infection has been shown to be a strong predictor for an abnormal dual X-ray absorptionmetry testing and is potentially a risk for fractures at older ages. This paper reviews management issues for osteoporosis specific to the population with HIV, including both prevention and treatment strategies.&lt;/p></description></item><item><title>2X to 3X higher hip fracture rate in Asia in past 30 years</title><link>/posts/2x-to-3x-higher-hip-fracture-rate-in-asia-in-past-30-years.html</link><pubDate>Sat, 18 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/2x-to-3x-higher-hip-fracture-rate-in-asia-in-past-30-years.html</guid><description>&lt;h1 id="osteoporosis-in-asia-a-call-to-action">Osteoporosis in Asia: A Call to Action.&lt;/h1>
&lt;p>Curr Osteoporos Rep. 2012 Aug 17.&lt;/p>
&lt;p>Mithal A, Kaur P.&lt;/p>
&lt;p>Division of Endocrinology and Diabetes, Medanta the Medicity, Sector 38, Gurgaon, Haryana, 122001, India, &lt;a href="mailto:ambrishmithal@hotmail.com">ambrishmithal@hotmail.com&lt;/a>.&lt;/p>
&lt;p>Asia is witnessing a rapid growth in its aging population. Yet osteoporosis in this region has received relatively little attention.&lt;/p>
&lt;p>Hip fracture rates have increased by &lt;strong>2- to 3-fold&lt;/strong> in most Asian countries during the past 30 years.&lt;/p>
&lt;p>Lack of quality epidemiologic data, widespread vitamin D deficiency, low dietary calcium intakes, and uneven access to diagnostic and therapeutic facilities are some of the major challenges faced in this region.&lt;/p></description></item><item><title>Vitamin D intervention stopped bone loss in those mice getting too much alcohol</title><link>/posts/vitamin-d-intervention-stopped-bone-loss-in-those-mice-getting-too-much-alcohol.html</link><pubDate>Wed, 15 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-intervention-stopped-bone-loss-in-those-mice-getting-too-much-alcohol.html</guid><description>&lt;h1 id="vitamin-d-supplementation-protects-against-bone-loss-associated-with-chronic-alcohol-administration-in-female-mice">Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice&lt;/h1>
&lt;p>10.1124/jpet.112.197038&lt;/p>
&lt;p>Journal of Pharocology and Experimentgal Therapeutics August 14, 2012&lt;/p>
&lt;p>Kelly E Mercer1, Rebecca A Wynne2, Oxana P Lazarenko2, Charles K. Lumpkin1, William R Hogue1, Larry J. Suva1, Jin-Ran Chen1, Andrew Z Mason3, Thomas M Badger1 and Martin J.J. Ronis1, &lt;a href="mailto:ronismartinj@uams.edu">ronismartinj@uams.edu&lt;/a>&lt;/p>
&lt;p>1 University of Arkansas for Medical Sciences;&lt;/p>
&lt;p>2 Arkansas Children&amp;rsquo;s Nutrition Center;&lt;/p>
&lt;p>3 California State University&lt;/p></description></item><item><title>Calcium and bone disorders in pregnancy</title><link>/posts/calcium-and-bone-disorders-in-pregnancy.html</link><pubDate>Sun, 12 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/calcium-and-bone-disorders-in-pregnancy.html</guid><description>&lt;p>Indian J Endocrinol Metab. 2012 May-Jun; 16(3): 358–363, &lt;a href="https://doi.org/10.4103/2230-8210.95665">doi: 10.4103/2230-8210.95665&lt;/a>, PMCID: PMC3354840&lt;/p>
&lt;p>Shriraam Mahadevan, V. Kumaravel,1 and R. Bharath2&lt;/p>
&lt;p>Department of Clinical Endocrinology, Dr. E. V. Kalyani Medical Centre, Chennai, India&lt;/p>
&lt;p>1 Department of Clinical Endocrinology, Alpha Hospital and Research Centre, Madurai, India&lt;/p>
&lt;p>2 Department of Endocrinology, Chettinad Medical College and Research Institute, Chennai, India&lt;/p>
&lt;p>Corresponding Author: Dr. Shriraam Mahadevan, Department of Clinical Endocrinology, Dr. E. V. Kalyani Medical Centre, 4, Radhakrishnan Salai, Mylapore, Chennai 600004, India. E-mail: &lt;a href="mailto:mshriraam@gmail.com">mshriraam@gmail.com&lt;/a>&lt;/p></description></item><item><title>Osteoporosis and vitamin D are important in men too – 10 years after women</title><link>/posts/osteoporosis-and-vitamin-d-are-important-in-men-too-10-years-after-women.html</link><pubDate>Wed, 08 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-and-vitamin-d-are-important-in-men-too-10-years-after-women.html</guid><description/></item><item><title>5X increase in hip fracture rates in 65 years - 1998</title><link>/posts/5x-increase-in-hip-fracture-rates-in-65-years-1998.html</link><pubDate>Mon, 06 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/5x-increase-in-hip-fracture-rates-in-65-years-1998.html</guid><description>&lt;h3 id="long-term-trends-in-hip-fracture-prevalence-the-influence-of-hip-fracture-incidence-and-survival">Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival.&lt;/h3>
&lt;p>Osteoporos Int. 1998;8(1):68-74.&lt;/p>
&lt;p>Melton LJ 3rd, Therneau TM, Larson DR.&lt;/p>
&lt;p>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.&lt;/p>
&lt;p>In this population-based descriptive study covering the 65-year period, 1928-92, there was a &lt;strong>5-fold increase in hip fracture&lt;/strong> prevalence among Rochester, Minnesota residents between 1928-42 and 1973-82, from 135.8 to 675.8 per 100,000. This change was dictated almost entirely by an increase in the incidence of first hip fractures due to moderate trauma (n = 2058) that was observed among Rochester women through 1950, and among men through 1980, that affected all age groups. Declining incidence rates thereafter led to a 9% fall in hip fracture prevalence from 1973-82 to 1983-92 to a rate of 612.7 per 100,000. A 13.7-year increase in age at first hip fracture over the study period was accounted for by aging of the underlying population, and a comparable 13.9-year increase in the age at death following hip fracture appeared to result from improved survival in the population generally. Thus, trends in hip fracture prevalence were mainly determined by changes in incidence &lt;strong>rather than relative changes in age at onset and death following hip fracture.&lt;/strong>&lt;/p></description></item><item><title>Hip fractures reduced 30 percent with 800 IU of vitamin D – meta-analysis</title><link>/posts/hip-fractures-reduced-30-percent-with-800-iu-of-vitamin-d-meta-analysis.html</link><pubDate>Fri, 06 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/hip-fractures-reduced-30-percent-with-800-iu-of-vitamin-d-meta-analysis.html</guid><description>&lt;h3 id="a-pooled-analysis-of-vitamin-d-dose-requirements-for-fracture-prevention">A pooled analysis of vitamin D dose requirements for fracture prevention.&lt;/h3>
&lt;p>N Engl J Med. 2012 Jul 5;367(1):40-9.&lt;/p>
&lt;p>Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R, Dawson-Hughes B.&lt;/p>
&lt;p>Center on Aging and Mobility, University of Zurich and Waid City Hospital, Zurich, Switzerland.&lt;/p>
&lt;p>BACKGROUND: The results of meta-analyses examining the relationship between vitamin D supplementation and fracture reduction have been inconsistent.&lt;/p></description></item></channel></rss>